Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ

International Journal of Cancer

Volumn 83, Issue 3, 1999, Pages 314-317

  Wassberg, Cecilia ^a,b   Thörn, Magnus ^a,b   Yuen, Jonathan ^b   Hakulinen, Timo ^c,d   Ringborg, Ulrik ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d FINNISH CANCER REGISTRY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOMA IN SITU; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; RISK; SEX FACTORS; SKIN NEOPLASMS;

EID: 0344418684     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991029)83:3<314::AID-IJC5>3.0.CO;2-9     Document Type: Article

References (26)

1. ACKERMAN, A.B., Clinical diagnosis of malignant melanoma in situ. In: A.B. Ackerman (ed.), Pathology of malignant melanoma, pp. 57-58, Masson, New York (1981).
2. ADAMI, J., FRISCH, M., YUEN, J., GLIMELIUS, B. and MELBY, M., Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Brit. Med. J., 310, 1491-1495 (1995).
3. BERGMAN, W., WATSON, P., DE JONG, J., LYNCH, H.T. and FUSARO, R.M., Systemic cancer and the FAMMM syndrome. Brit. J. Cancer, 61, 932-936 (1990).
4. CANCER REGISTRY, Cancer incidence in Sweden 1958-1992, National Board of Health and Welfare, Stockholm (1994).
5. CLARK, W.H., JR., Malignant melanoma in situ. Hum. Pathol., 21, 1197-1198 (1990).
6. DE GRUIJL, F.R. and FORBES, P.D., UV-induced skin cancer in a hairless mouse model. Bioessays, 17, 651-660 (1995).
7. ELWOOD, J.M. and JOPSON, J., Melanoma and sun exposure: an overview of published studies. Int. J. Cancer, 73, 198-203 (1997).
8. FRÖDIN, J.E., ERICSSON, J. and BARLOW, L., Multiple primary malignant tumors in a national cancer registry - reability of reporting. Acta Oncol., 36, 465-469 (1997).
9. GOLDSTEIN, A.M., FRASER, M.C., STRUEWING, J.P., HUSSUSSIAN, C.J., RANADE, K., ZAMETKIN, D.P., FONTAINE, L.S., ORGANIC, S.M., DRACOPOLI, N.C., CLARK, W.H., JR, and TUCKER, M.A., Increased risk of pancreatic cancer in melanoma-prone kindreds with p16 INK4 mutations. N. Engl. J. Med., 333, 970-974 (1995).
10. GREEN, M.H., YOUNG, T.I. and CLARK, W.H., JR., Malignant melanoma in renal transplant recipients. Lancet, 1, 1196-1198 (1981).
11. GUTMAN, M., CNAAN, A., INBAR, M., SHAFIR, R., CHAITCHIK, S., ROZIN, R.R. and KLAUSNER, M.J., Are malignant melanoma patients at higher risk for a second cancer? Cancer, 68, 660-665 (1991).
12. KRICKER, A., ARMSTRONG, B.K., ENGLISH, D.R. and HEENAN, P.J., Does intermittent sun exposure cause basal cell carcinoma? A case-control study in western Australia. Int. J. Cancer, 60, 489-494 (1995).
13. KRIPKE, M.L., Effects of UV radiation on tumor immunity. J. nat. Cancer Inst., 82, 1392-1396 (1990).
14. LEVER, W., Histopathotogy of the skin, p. 400, Lippincott, Philadelphia (1949).
15. MATTSSON, B. and WALLGREN, A., Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol. Oncol., 23, 305-313 (1984).
16. MOORE, D.H., SCHNEIDER, J.S. and SAGEBIEL, R.W., Discordance of risk factors for invasive and non-invasive melanoma. Lancet, 335, 1523-1524 (1990).
17. NATIONAL INSTITUTES OF HEALTH, Consensus development conference statement on diagnosis and treatment of early melanoma, January 27-29, 1992. Amer. J. Dermatopathol., 15, 34-43, 46-51 (1993).
18. ÖSTERLIND, A., Etiology and epidemiology of melanoma and skin neoplasms. Curr. Opin. Oncol., 3, 355-359 (1991).
19. PLATZ, A., HANSSON, J., MÅNSSON-BRAHME, E., LAGERLÖF, B., LINDER, S., LUNDQVIST, E., SEVIGNY, P., INGANÄS, M. and RINGBORG, U., Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J. nat. Cancer Inst., 89, 697-702 (1997).
20. SCHALLREUTER, K.U., LEVENIG, C. and BERGER, J., Cutaneous malignant melanomas with other coexisting neoplasms: a true association? Dermatology, 186, 12-17 (1993).
21. SNELL, R.S. and BISCHITZ, P.G., The effect of large doses of estrogen and progesterone on melanin pigmentation. J. Invest. Dermatol., 35, 73-82 (1960).
22. STEDMAN, K.E., MOORE, G.E. and MORGAN, R.T., Estrogen receptor proteins in diverse human tumors. Arch. Surg., 115, 244-248 (1980).
23. THÖRN, M., PONTÉN, F., JOHANSSON, A.-M. and BERGSTRÖM, R., Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden, 1968-1992. Cancer Detect. Prevent., 22, 430-437 (1998).
24. TRAVIS, L.B., CURTIS, R.E., BOICE, J.D., JR., HANKEY, B.F. and FRAUMENI, J.F., Jr., Second cancers following non-Hodgkin's lymphoma. Cancer, 67, 2002-2009 (1991).
25. WASSBERG, C., THÖRN, M., YUEN, J., RINGBORG, U. and HAKULINEN, T., Second primary cancers in patients with malignant melanoma: a population-based study in Sweden. Brit. J. Cancer, 73, 255-259 (1996).
26. WORLD HEALTH ORGANIZATION, Manual of the international statistical classification of diseases, injuries, and causes of death (7th rev.), World Health Organization, Geneva (1957).